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S U M M A R Y
Objective: The objective of this study was to delineate the trends in early and late diagnosis of HIV-1
infection in newly diagnosed Tokyoites.
Methods: The BED assay was used to identify cases diagnosed at an early stage of infection. BED-positive
non-AIDS cases with a CD4 cell count 200/ml were deﬁned as cases with recent infection. The rates of
AIDS and recent infection in 809 newly diagnosed Tokyoites during 2002–2010 were analyzed.
Results: The AIDS rate was 22.5%. AIDS patients were older (40.4 years) than non-AIDS patients (35.0
years), and a smaller proportion were men who have sex with men (MSM) in AIDS patients (81.7%) than
in non-AIDS patients (89.9%). The AIDS rate was persistently lower (14.3%) in 29-year-old than in
30-year-old MSM. The rate of recent infection was 24.4%. Individuals with recent infection (33.0 years
old) were younger than the others (37.2 years). The rate of recent infection was lower (18.5%) in MSM
aged 40 years than in those aged 39 years during the study period, except for 2007 and 2008.
Conclusions: Younger MSM Tokyoites appear to be aware of the risk of their sexual behavior, sufﬁcient to
take voluntary HIV testing repeatedly, resulting in early diagnosis. Older MSM did not take HIV testing
frequently enough and may be a good target for campaigns promoting testing.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The overall growth of the global AIDS epidemic appears to have
stabilized. The annual number of new cases of HIV infection has
been in steady decline since the late 1990s.1 In Japan, however, the
annual number of newly diagnosed cases has almost doubled
during the most recent decade (791 cases in 2000 and 1544 cases in
2010), although the prevalence of HIV in the adult population
remains <0.1%.2 The distribution of these cases is heavily
concentrated in large cities, and approximately 35% of the newly
diagnosed cases have been identiﬁed in Tokyo.3
Early diagnosis of HIV infection is critically important because
some AIDS-deﬁning diseases are fatal, even in the era of combination
antiretroviral treatment (ART); also the introduction of ART after the
development of AIDS is often complicated with immune reconsti-
tution inﬂammatory syndrome (IRIS).4,5 In this regard, the
introduction of ART at the early stages seems to signiﬁcantly reduce
the sexual transmission of HIV-1.6,7 Thus, it is important to identify
newly infected individuals and provide early ART to reduce the* Corresponding author. Tel.: +81 3 3202 7181; fax: +81 3 5273 6483.
E-mail address: higatana@acc.ncgm.go.jp (H. Gatanaga).
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proportion of patients diagnosed at the early stage of an HIV
infection in the newly diagnosed cases is also useful for planning and
evaluation of any prevention program and for resource allocation.8,9
However, it is usually difﬁcult to distinguish recent from long-
standing HIV infections except for acute symptomatic infections.10
Simple prediction of the infection time from CD4 cell counts appears
inaccurate because the disease progression rate varies enormously
among infected individuals.11 The BED HIV-1 capture enzyme
immunoassay (BED assay) uses the branched peptide to detect HIV-
1 IgG antibodies from all subtypes (i.e., HIV-1 B, E, and D gp41
immunodominant sequences are included on a branched peptide
used in the assay) and measures levels of anti-HIV-1 IgG relative to
total IgG.12 Since the ratio of anti-HIV-1 IgG to total IgG increases
with time shortly after HIV-1 infection, the HIV-1-infected patient is
considered to have recently acquired the infection when the
normalized optical density (ODn) is less than 0.8 on the BED assay
(ODn reaches 0.8 on average 197 days after seroconversion.).13
The present study was an attempt to delineate the trends in
early diagnosis of HIV-1 infection in Tokyo from 2002 to 2010 by
using the BED assay. The aim of this analysis was to enhance our
understanding of the status of HIV-1 spread in Tokyo and to help in
the design of strategies to control the HIV-1 epidemic in Japan.ses. Published by Elsevier Ltd. All rights reserved.
Table 1
New cases of HIV-1-infected patients diagnosed between 2002 and 2010
Japana Tokyob This study
Number of cases 11 673 4048 809
Age, years (mean  SD) 38.0  11.8c 37.7  11.9d 36.2  11.0
Males 10 721 (91.8%)c 3819 (94.3%) 778 (96.2%)
Men having sex
with men
6408 (59.8%)c 2780 (72.8%)c 685 (88.0%)
Japanese 10 335 (88.5%)d 3673 (90.7%) 741 (91.6%)
AIDS cases 3551 (30.4%)c 885 (21.9%) 182 (22.5%)
Statistical analyses were performed by one-way ANOVA and Tukey test, or Chi-
square test.
a Provided by the National AIDS Surveillance Committee (the Ministry of Health,
Labor, and Welfare of the Japanese Government).
b Provided by the Bureau of Social Welfare and Public Health, Tokyo.
c p < 0.001, compared with the study participants.
d p < 0.01 compared with the study participants.
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2.1. Newly diagnosed patients
This study included all ART-naı¨ve HIV-1-infected individuals
who met the following criteria: (1) those who visited the AIDS
Clinical Center, National Center for Global Health and Medicine,
Tokyo, between 2002 and 2010 within 30 days of their diagnosis
with an HIV-1 infection and (2) availability of plasma samples
taken at the ﬁrst visit under signed informed consent for use in
viral, immunological, and epidemiological studies. Participant
information including CD4 count, HIV-1 load, age at the ﬁrst visit,
gender, nationality, probable HIV-1 transmission route, and
history of HIV testing, were collected from the medical records.
According to the Japanese law for infection control, physicians are
obliged to report newly diagnosed HIV/AIDS cases to the National
AIDS Surveillance Committee (the Ministry of Health, Labor, and
Welfare of the Japanese Government). A total of 11 673 HIV/AIDS
cases nationally, including 4048 cases diagnosed in Tokyo (Tokyo
cases), which were entered into the registry of this committee from
2002 to 2010, were used as the control populations to evaluate the
representativeness of the patients enrolled in the present study
(AIDS Clinical Center cases).2,3 Plasma samples obtained from the
participants were stored at 80 8C. The viral subtype in each case
was determined from the HIV-1 protease–reverse transcriptase
sequence (which was analyzed for drug resistance genotyping) by
the neighbor-joining method using the Genetic-Win system
(Software Development, Tokyo).14
This study was conducted according to the principles of the
Declaration of Helsinki and was approved by the ethics committee
of the National Center for Global Health and Medicine.
2.2. BED assay
The BED HIV-1 capture enzyme immunoassay (BED assay;
Calypte Biomedical Corp., Portland, OR, USA) was used to estimate
the time of HIV-1 infection.12 In accordance with the manufac-
turer’s instructions, 5 ml of plasma was diluted with 500 ml of the
diluent in the kit, and the proportion of anti-HIV-1-speciﬁc IgG to
the total IgG in the sample was measured by optical density (OD).
The OD values of the test specimens were normalized (ODn)
relative to the value of a calibrator (specimen OD/calibrator OD) to
minimize inter-run variation. Samples with ODn 0.8 were
considered to be from individuals who had seroconverted within
197 days and were deﬁned as BED-positive.13 BED-positive non-
AIDS cases with CD4 cell counts 200/ml were deﬁned as
individuals with recent infection. The others were deﬁned as
chronic infection.
2.3. Statistical analysis
Differences in demographic data including age, gender, risk
behavior, nationality, and AIDS development among the AIDS
Clinical Center cases, national cases, and Tokyo cases, were
examined for signiﬁcance using one-way analysis of variance
(ANOVA) and the Tukey test, or Pearson’s Chi-square test.
Differences in demographic data including age, CD4 count,
logarithmic HIV-1 viral load, nationality, transmission category,
HIV-1 subtype, cue for HIV diagnosis, and history of HIV testing,
between AIDS and non-AIDS patients and between recent and
chronic infection, were examined for signiﬁcance using the t-test
or Pearson’s Chi-square test. To estimate the correlation with the
development of AIDS, binominal logistic regression analysis
including age, nationality (Japanese or not), and transmission
category (men having sex with men (MSM) or not) was performed.
A p-value of less than 5% denoted statistical signiﬁcance. Statisticalanalyses were performed with SPSS Statistics 17.0 (IBM Japan Inc.,
Tokyo, Japan) and Stat Mate II (NANKODO, Tokyo).
3. Results
3.1. Newly diagnosed cases of HIV-1 infection
The study subjects were 809 ART-naı¨ve HIV-1-infected
patients. All of them had visited the AIDS Clinical Center, National
Center for Global Health and Medicine, Tokyo, within 30 days of
the diagnosis of HIV-1 infection (median 8 days) between 2002 and
2010. They included 741 Japanese, 35 Asians other than Japanese,
and 33 from other countries. They represented 20.0% of the total
number of newly diagnosed Tokyoite cases during the same period
(Table 1). There were no signiﬁcant differences in the proportion of
AIDS (22.5% vs. 21.9%), percentage of males (96.2% vs. 94.3%), or
proportion of Japanese (91.6% vs. 90.7%) between our study
patients and those of the Tokyo registry, although our patients
included a signiﬁcantly smaller proportion of AIDS cases (22.5% vs.
30.4%) and signiﬁcantly larger population of male patients (96.2%
vs. 91.8%) and Japanese patients (91.6% vs. 88.5%) compared with
the patients of the national registry. Furthermore, our patients
were signiﬁcantly younger than the patients of the Tokyo and
national registries (36.2 vs. 37.7 and 38.0 years), and the
proportion of MSM among male patients was signiﬁcantly higher
than in the Tokyo and national registries (88.0% vs. 72.8% and
59.8%).
Subtype analysis successfully determined the HIV-1 subtype in
807 patients (99.8%); the majority were infected with HIV-1
subtype B (742 patients, 91.9%), while 5.7% were infected with
HIV-1 subtype AE, which is comparable to previously published
subtype data in Japan.14 The HIV-1 subtype could not be
determined in two patients because the viral load was below
the detection limit (<40 copies/ml), although they were not being
treated with anti-HIV drugs.
3.2. Features of AIDS patients
Among the 809 cases, 182 (22.5%, 95% conﬁdence interval (95%
CI) 19.6–25.4) had already developed AIDS at the ﬁrst visit, while
the other 627 were non-AIDS cases (Table 2). AIDS cases were
signiﬁcantly older (40.4 years, 95% CI 38.8–41.9 vs. 35.0 years, 95%
CI 34.2–35.9), and as expected, had lower CD4 counts (61.7/ml, 95%
CI 50.6–72.8 vs. 318.0/ml, 95% CI 303.0–333.0) and higher viral
loads (5.22 log VL/ml, 95% CI 5.13–5.31 vs. 4.63 log VL/ml, 95% CI
4.56–4.70) than non-AIDS patients. There were no signiﬁcant
differences in nationality (Japanese 91.8%, 95% CI 87.8–95.8 vs.
91.5%, 95% CI 89.4–93.7) or HIV-1 subtype (subtype B 89.0%, 95% CI
84.5–93.6 vs. 92.5%, 95% CI 90.4–94.6) between AIDS and non-AIDS
Table 2
Demographics of participants with and without AIDS
AIDS (n = 182) Non-AIDS (n = 627) p-Valuea
Mean (95% CI) Mean (95% CI)
Age (years) 40.4 (38.8–41.9) 35.0 (34.2–35.9) <0.001
CD4 count /ml 61.7 (50.6–72.8) 318.0 (303.0–333.0) <0.001
Log viral load/ml 5.22 (5.13–5.31) 4.63 (4.56–4.70) <0.001
n % (95% CI) n % (95% CI)
Nationality 0.424
Japan 167 91.8 (87.8–95.8) 574 91.5 (89.4–93.7)
Asia other than Japan 11 6.0 (3.3–10.8) 24 3.8 (2.6–5.7)
North and South America 2 1.1 (0.2–4.0) 17 2.7 (1.7–4.3)
Africa 2 1.1 (0.2–4.0) 6 1.0 (0.4–2.1)
East and West Europe 0 0 (0–2.0) 4 0.6 (0.2–1.6)
Oceania 0 0 (0–2.0) 2 0.3 (0–1.1)
Transmission category
Male 175 96.2 (93.4–98.9) 603 96.2 (94.7–97.7) 0.024
MSM 143 81.7 (76.0–87.4) 542 89.9 (87.5–92.3)
Heterosexual 21 12.0 (7.2–16.8) 43 7.1 (5.4–9.6)
IDU 1 0.6 (0–3.2) 2 0.3 (0.1–1.2)
Unknown 10 5.7 (3.0–10.5) 16 2.7 (1.6–4.3)
Female 7 3.8 (1.7–7.9) 24 3.8 (2.6–5.7) -
Heterosexual 7 100 (46.8–100) 24 100 (100–100)
Subtype 0.351
B 162 89.0 (84.5–93.6) 580 92.5 (90.4–94.6)
AE 16 8.8 (5.4–14.3) 30 4.8 (3.4–6.8)
C 1 0.5 (0–3.0) 7 1.1 (0.5–2.3)
G 2 1.1 (0.2–4.0) 3 0.5 (0.1–1.4)
AG 1 0.5 (0–3.0) 3 0.5 (0.1–1.4)
A 0 0 (0–2.0) 2 0.3 (0–1.1)
Unknown 0 0 (0–2.0) 2 0.3 (0–1.1)
Cue for HIV diagnosis <0.001
Voluntary testing 12 6.6 (3.7–11.5) 283 45.1 (41.2–49.0)
Provider-initiated testing 167 91.8 (87.8–95.8) 338 53.9 (50.0–57.8)
Unknown 3 1.6 (0.4–4.8) 6 1.0 (0.4–2.1)
Previous testing <0.001
Yes 29 15.9 (10.6–21.3) 282 45.0 (41.1–48.9)
No 65 35.7 (28.8–42.7) 254 40.5 (36.7–44.4)
Unknown 88 48.4 (41.1–55.6) 91 14.5 (11.8–17.3)
BED assay <0.001
Recent (ODn 0.8) 47 25.8 (19.5–32.2) 255 40.7 (36.8–44.5)
Chronic (ODn >0.8) 135 74.2 (67.8–80.5) 372 59.3 (55.5–63.2)
CI, conﬁdence interval; MSM, men who have sex with men; IDU, intravenous drug user; ODn, normalized optical density.
a By t-test or Pearson’s Chi-square test.
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frequent transmission route in both groups, and still more frequent
in non-AIDS cases (89.9%, 95% CI 87.5–92.3) than in AIDS cases
(81.7%, 95% CI 76.0–87.4). A larger proportion of patients in the
non-AIDS group than in the AIDS group had undertaken previous
HIV testing (45.0%, 95% CI 41.1–48.9 vs. 15.9%, 95% CI 10.6–21.3)
and had been diagnosed with HIV-1 infection by voluntary testing
(45.1%, 95% CI 41.2–49.0 vs. 6.6%, 95% CI 3.7–11.5), suggesting that
repeated voluntary testing may prevent disease progression to
AIDS in the high-risk groups.
Binominal logistic regression analysis of age, nationality
(Japanese or not), and transmission category (MSM or not)
identiﬁed age as the most signiﬁcant factor associated with the
development of AIDS (per 1-year increment, (hazard ratio) HR
1.041, 95% CI 1.026–1.057; p < 0.001).
To delineate the trends in late diagnosis of HIV-1 infection, the
annual rates of AIDS cases in newly-diagnosed HIV-1-infected
patients were plotted through the study period. The rate of AIDS
cases remained around 30% between 2002 and 2004. It decreased
to 15.0% in 2005, but then showed a gradual increase annually,
reaching 24.8% in 2010 (Figure 1). To identify the population that
inﬂuenced the increase in the rate of AIDS cases in the most recent
years, we selected and categorized the study participants based on
their features. Speciﬁcally, we focused on MSM patients, because
85% of our patients were MSM. Based on the above results of thesigniﬁcance of age in the binominal logistic regression analysis in
the development of AIDS, we examined the effect of age in more
detail by dividing the MSM patients into three age groups: those
aged 29 years (217 patients, 31.7%), 30–39 years (273 patients,
39.9%), and 40 years (195 patients, 28.5%). In the 40 years MSM
group, the rate was higher than 50% between 2002 and 2004, but
decreased to 21.4% in 2005 and further decreased to 14.3% in 2006,
but gradually increased and reached 30% in 2009 and 2010
(Figure 1). On the other hand, in the 29 years MSM group, the
AIDS rate was steadily lower than 20%, indicating that most young
HIV-1-infected MSM were diagnosed before the development of
AIDS throughout the study period. The AIDS rate in the 30–39 years
MSM group was between those of the other two groups during
most of the study period. A signiﬁcantly larger proportion of
patients in the 29 years MSM group had undergone voluntary
HIV testing (43.8%, p = 0.002, Pearson’s Chi-square test) and
diagnosis with HIV (48.8%, p < 0.001, Pearson’s Chi-square test),
compared with the 30–39 years MSM group (43.6% and 36.6%,
respectively) and the 40 years MSM group (34.9% and 32.3%,
respectively). These results suggest that repeated voluntary testing
may have prevented disease progression to AIDS in the younger
MSM groups. The high rate of AIDS in all the study participants
observed in 2002–2004 seemed mainly due to the 40-year-old
MSM. Furthermore, the gradual increase in the AIDS rate in the
40-year-old MSM since 2006 also seemed to have contributed to
Figure 1. Annual rate of AIDS in newly diagnosed HIV-1-infected individuals. The annual AIDS rate for all study participants (809 patients; left panel), and men who have sex
with men (MSM) categorized by age: 29 years (n = 217), 30–39 years (n = 273), and 40 years (n = 195) (right panel). The 95% conﬁdence intervals are also shown in the left
panel. Data including 95% conﬁdence intervals for the MSM are provided in the Supplementary Information (Table S1).
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main target for interventions aimed at promoting HIV testing for
early diagnosis and prevention of the development of AIDS.
3.3. Trends in early HIV diagnosis
To identify individuals with recent HIV-1 infection, we
performed a BED assay for the 809 study participants. Before
analysis of the results, we dealt with the problem of potentialTable 3
Demographics of participants with recent and chronic infection
Recent (n = 197) 
Mean (95% CI) 
Age (years) 33.0 (31.7–34.3) 
CD4 count /ml 423.2 (399.2–447.3) 
Log viral load/ml 4.61 (4.46–4.76) 
n % (95% CI) 
Nationality 
Japan 189 95.9 (93.2–98.7) 
Asia other than Japan 2 1.0 (0.2–3.7) 
North and South America 3 1.5 (0.4–4.4) 
Africa 1 0.5 (0–2.8) 
East and West Europe 1 0.5 (0–2.8) 
Oceania 1 0.5 (0–2.8) 
Transmission category
Male 192 97.5 (95.3–99.7) 
MSM 177 92.2 (88.4–96.0) 
Heterosexual 11 5.7 (3.1–10.2) 
IDU 0 0 (0–1.9) 
Unknown 4 2.1 (0.7–5.3) 
Female 5 2.5 (1.0–5.9) 
Heterosexual 5 100 (34.4–100) 
Subtype 
B 188 95.4 (92.5–98.3) 
AE 4 2.0 (0.7–5.2) 
C 1 0.5 (0–2.8) 
G 1 0.5 (0–2.8) 
AG 1 0.5 (0–2.8) 
A 0 0 (0–1.9) 
Unknown 2 1.0 (0.2–3.7) 
Cue for HIV diagnosis 
Voluntary testing 102 51.8 (44.8–58.8) 
Provider-initiated testing 94 47.7 (40.7–54.7) 
Unknown 1 0.5 (0–2.8) 
Previous testing 
Yes 116 58.9 (52.0–65.8) 
No 57 28.9 (22.6–35.3) 
Unknown 24 12.2 (7.6–16.8) 
CI, conﬁdence interval; MSM, men who have sex with men; IDU, intravenous drug use
a By t-test or Pearson’s Chi-square test.misclassiﬁcation. Previous studies reported small levels of anti-
HIV-1-speciﬁc IgG relative to the total IgG in cases with both
recent HIV-1 infection and long-standing chronic cases with
severe immunodeﬁciency, which could result in false classiﬁca-
tion of chronic cases as recent infection.12,15,16 To tackle this
problem, previous studies classiﬁed AIDS cases and cases with
CD4 cell counts <200/ml as chronic infection cases, in accordance
with the Joint United Nations Programme on HIV/AIDS (UNAIDS)/
World Health Organization (WHO) guidelines.17–21 We appliedChronic (n = 612) p-Valuea
Mean (95% CI)
37.2 (36.3–38.1) <0.001
207.9 (193.3–222.4) <0.001
4.81 (4.74–4.87) 0.005
n % (95% CI)
0.101
552 90.2 (87.8–92.6)
33 5.4 (3.9–7.6)
16 2.6 (1.6–4.2)
7 1.1 (0.5–2.4)
3 0.5 (0.1–1.4)
1 0.2 (0–0.9)
586 95.8 (94.2–97.3) 0.314
508 86.7 (83.9–89.4)
53 9.0 (7.0–11.8)
3 0.5 (0.1–1.5)
22 3.8 (2.5–5.7)
26 4.2 (2.9–6.2) -
26 100 (81.5–100)
0.029
554 90.5 (88.2–92.8)
42 6.9 (5.2–9.3)
7 1.1 (0.5–2.4)
4 0.7 (0.2–1.7)
3 0.5 (0.1–1.4)
2 0.3 (0–1.2)
0 0 (0–0.6)
<0.001
193 31.5 (27.9–35.2)
411 67.2 (63.4–70.9)
8 1.3 (0.6–2.6)
<0.001
195 31.9 (28.2–35.6)
262 42.8 (38.9–46.7)
155 25.3 (21.9–28.8)
r.
Figure 2. Annual rate of recent infection in newly diagnosed HIV-1-infected cases. The annual rate of recent infection in all study participants (809 patients; left panel), and in
men who have sex with men (MSM) categorized by age: 29 years (n = 217), 30–39 years (n = 273), and 40 years (n = 195) (right panel). The 95% conﬁdence intervals are
also shown in the left panel. Data including 95% conﬁdence intervals for the MSM are provided in the Supplementary Information (Table S2).
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positive non-AIDS cases with CD4 cell counts 200/ml as recent
infection.
In the 456 non-AIDS cases with CD4 cell counts 200/ml, 197
cases were BED-positive and classiﬁed as recent infection (43.2%;
24.4% of the total cases) (Table 3). BED-negative cases, AIDS cases,
and cases with CD4 cell counts <200/ml were classiﬁed as chronic
infection. Patients with recent infection were younger (33.0 years,
95% CI 31.7–34.3 vs. 37.2 years, 95% CI 36.3–38.1) and had higher
CD4 counts (423.2/ml, 95% CI 399.2–447.3 vs. 207.9/ml, 95% CI
193.3–222.4), as expected, and lower viral load (4.61 log VL/ml,
95% CI 4.46–4.76 vs. 4.81 log VL/ml, 95% CI 4.74–4.87), compared to
patients with chronic infection. A larger proportion of recent
infection (95.4%, 95% CI 92.5–98.3) was caused by HIV-1 subtype B
than in those with chronic infection (90.5%, 95% CI 88.2–92.8).
There were no signiﬁcant differences in the nationality and
transmission category between recent and chronic infection cases
(Pearson’s Chi-square test), although the proportion of Japanese
patients was higher in recent infection (95.9%, 95% CI 93.2–98.7)
than in chronic infection (90.2%, 95% CI 87.8–92.6) (p = 0.012, Chi-
square test). A signiﬁcantly larger proportion of patients under-
went previous HIV testing (58.9%, 95% CI 52.0–65.8 vs. 31.9%, 95%
CI 28.2–35.6) and were diagnosed with HIV-1 infection by
voluntary testing (51.8%, 95% CI 44.8–58.8 vs. 31.5%, 95% CI
27.9–35.2) among recent infection cases than chronic infection
cases (p < 0.001 in both, Pearson’s Chi-square test).
To delineate the trends in early diagnosis of HIV-1 infection,
the annual rate of recent infection in all 809 study participants
was plotted over the study period (Figure 2). The rate was stable at
20% between 2002 and 2010, except for 2007 (26.1%) and 2008
(31.9%), when a slight increase was evident. In order to identify
the population that inﬂuenced the annual trends of early
diagnosis, we focused on MSM patients and again divided them
into three age groups: 29 years, 30–39 years, and 40 years. The
rates of recent infection in the 29 and 40 years MSM groups
were the highest and the lowest, respectively, in most years of the
study period. The rate in the 29 years MSM group was high,
ranging from 25.0% to 46.2% between 2002 and 2005, but it
decreased to 19.0% in 2006, and increased again in 2007 and
remained around 35% between 2007 and 2010. The rate of recent
infection in the 40-year-old MSM group was steadily low at
10% between 2002 and 2006, but increased in 2007 to 25.9% and
2008 to 35.3%, then decreased to around 15% in 2009 and 2010.
The rate in the 30–39-year-old MSM ranged between those of the
other two groups during most part of the study period. These
results suggest that younger MSM tend to be diagnosed
persistently earlier, whereas older MSM are usually diagnosed
at a later stage of the HIV disease.4. Discussion
The present study analyzed the trends in the proportion of AIDS
patients and patients with recent infection among 809 new cases
of HIV-1-infection diagnosed between 2002 and 2010. This group
recruited from our AIDS Clinical Center represents 20.0% of the
total number of newly diagnosed Tokyoites during the same
period. We found that MSM, especially younger MSM, tend to be
diagnosed at an earlier stage before the development of AIDS,
probably because of frequent voluntary HIV testing. The propor-
tion of AIDS cases remained at a steady low level and the rate of
recent infection remained at a high level in younger MSM patients,
indicating that younger MSM are aware of the risk of their sexual
behavior sufﬁcient to take HIV testing repeatedly. On the other
hand, in the older MSM, the rate of AIDS was relatively high and the
rate of recent infection comparatively low, but transiently
increased in 2007 and 2008, suggesting that older MSM with a
high-risk of HIV infection usually do not take HIV testing
frequently and may respond to campaigns that promote such
tests. Interestingly, the Japan Foundation for AIDS Prevention
conducted several campaigns to promote voluntary HIV-1 testing
in 2007. A popular male Japanese singer took part in one such
campaign in July 2007, which was a great surprise among the
Japanese in general, and this was followed by an increase in
the number of voluntary HIV tests performed in 2007 and 2008.2
The event may have prompted older MSM at high risk to take
voluntary HIV testing, resulting in the transient increase in the rate
of early diagnosis for 2007 and 2008. The sharp decline in the rate
of early diagnosis observed in 2009 and 2010 in the older MSM
group coincided with reductions in the number of voluntary tests,2
and could be an omen of future increases in the number of AIDS
patients in this population. Early diagnosis followed by early
introduction of ART may reduce the spread of HIV-1 among MSM,
which could help to prevent an HIV epidemic in this popula-
tion.6,7,22 A strategy based on the promotion of voluntary testing
needs to be formulated, similar to the 2007 campaigns that
resulted in signiﬁcant increases in the rate of early diagnosis in
older MSM.
Discordant shifts were observed between the rates of AIDS and
recent infection. The reasons may be that AIDS usually develops
several years after HIV infection and that disease progression
varies enormously among infected individuals. Therefore, the
variable length of time during which HIV infection was ignored
resulted in the development of AIDS, the proportion of which does
not always correlate with the rate of recent infection in the same
year.11 Furthermore, disease progression has been suggested to
have become faster in a signiﬁcant portion of Japanese patients,
probably because the prevailing HIV-1 strains in Japan have
T. Hayashida et al. / International Journal of Infectious Diseases 16 (2012) e172–e177 e177adapted to the Japanese population by acquiring escape mutations
from immune pressure restricted by human leukocyte antigens
(HLAs) popular among the Japanese.23,24 Based on this point of
view, early diagnosis is even more important due to the shorter
asymptomatic period before the development of AIDS.
The majority of our study participants were infected with HIV-1
subtype B, and HIV-1 subtype B infection correlated signiﬁcantly
with MSM (crude odds ratio 37.9, p < 0.001; Chi-square test). The
non-AIDS patients were more likely to be infected with subtype B
than AIDS patients (crude odds ratio 1.59, p = 0.098). The same was
true for recent infection than chronic infection (crude odds ratio
2.81, p = 0.009). A previous Japan-wide survey also showed a close
relationship between subtype B and MSM in Japan; all cases
diagnosed with primary HIV-1 infection (n = 45) were caused by
subtype B, and such primary infections were signiﬁcantly frequent
among MSM.14 Considered together, the results indicate that
subtype B is the major currently prevalent strain in Japan,
especially among MSM, and such strains are probably adapting
to the Japanese population by repeated exposure to immune
pressure of the Japanese.
This study used case reporting-based surveillance to estimate
the number of new HIV-1 infections in Tokyoites between 2002
and 2010. The data were collected at a single center and thus may
have included some institutional bias. The study participants were
statistically younger and were more likely to be MSM than those of
the Tokyo registry. The BED assay was used in this study to
determine the rate of recent infection in the selection study group
and not to determine the national incidence rate. However, the
data from this study suggest the following target-speciﬁc
differential strategies for controlling the HIV epidemic and for
AIDS prevention in Tokyo: campaigns aimed at promoting testing
should be directed at older MSM for early diagnosis to prevent/halt
the progression of AIDS; commencement of ART for HIV-infected
younger MSM at early stages of the disease may effectively reduce
the number of new cases based on the control of current hot-spots
of HIV transmission among this group.
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